May 21, 2026 09:30AM
May 21, 2026 09:30AM
May 7, 2026 04:01PM
Apr 29, 2026 08:30AM
Apr 29, 2026 08:30AM
Apr 28, 2026 08:45AM
Apr 28, 2026 08:45AM Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel
Apr 17, 2026 08:30AM
Apr 17, 2026 08:30AM
Apr 14, 2026 12:03PM
Apr 14, 2026 12:00PM
Apr 8, 2026 09:02AM
Apr 8, 2026 08:52AM
Apr 8, 2026 06:01AM Oppenheimer on Gilead Sciences (GILD): 'Story Near-Term Remains Squarely HIV Focused'
Apr 7, 2026 09:33AM
Apr 7, 2026 08:32AM
Apr 7, 2026 08:30AM
Apr 1, 2026 04:13PM
Apr 1, 2026 04:13PM
Mar 31, 2026 06:19AM
Mar 24, 2026 03:02PM Clear Street Reiterates Buy Rating on Cullinan Oncology Inc. (CGEM)
Mar 24, 2026 06:36AM
Mar 24, 2026 05:23AM
Mar 23, 2026 06:30PM
Mar 23, 2026 06:15PM
Mar 23, 2026 06:15PM
Feb 25, 2026 01:50PM
Feb 25, 2026 01:44PM Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy
Feb 25, 2026 10:02AM
Feb 24, 2026 09:38AM
Feb 24, 2026 08:23AM
Feb 23, 2026 12:32PM
Feb 23, 2026 09:31AM
Feb 23, 2026 06:01AM
Feb 23, 2026 06:01AM Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
Feb 17, 2026 08:30AM
Feb 10, 2026 04:01PM
Dec 24, 2025 07:00AM
Dec 22, 2025 08:02AM
Dec 22, 2025 08:00AM
Dec 15, 2025 08:30AM
Dec 15, 2025 08:30AM Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial
Dec 12, 2025 10:31AM
Nov 18, 2025 05:09AM
Nov 18, 2025 05:00AM
Nov 13, 2025 08:30AM
Nov 13, 2025 08:30AM
Oct 31, 2025 08:00AM
Oct 30, 2025 04:02PM Gilead Sciences Announces Third Quarter 2025 Financial Results
Oct 19, 2025 08:30AM

1,154,895 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All